MedTrace Logo

A Study of Smoking Cessation Patterns in Participants Undergoing Lung Surgery

NCT04313361 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 290

Last updated 2025-04-27

No results posted yet for this study

Summary

The purpose of this study is to assess the current smoking status and smoking cessation attempts among smokers or recent smoking quitters during the perioperative period, to describe postoperative pulmonary complications (PPCs) and other postoperative complications (PCs) following a lung surgery, and to describe the smoking cessation methods and services patients received from their health care professionals (HCPs) and participant's satisfaction among participants with lung cancer, chronic obstructive pulmonary disorder (COPD), a pulmonary lesion (example, nodule, or ground glass opacity) or other pulmonary conditions who are admitted to the thoracic surgical unit of the participating hospitals in China.

Conditions

  • Lung Neoplasms
  • Pulmonary Disease, Chronic Obstructive

Interventions

OTHER

No intervention

No drug will be administered as part of this study.

Sponsors & Collaborators

  • Johnson & Johnson (China) Investment Ltd.

    lead INDUSTRY

Principal Investigators

  • Johnson & Johnson (China) Investment Ltd. Clinical Trial · Johnson & Johnson (China) Investment Ltd.

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-06
Primary Completion
2021-12-09
Completion
2021-12-09

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04313361 on ClinicalTrials.gov